Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2014 by University of Padova.
Recruitment status was  Recruiting
Information provided by:
University of Padova Identifier:
First received: August 26, 2008
Last updated: October 11, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)